258 results on '"L. Alberghina"'
Search Results
2. Are metabolic processes affected during astrogliosis? DiVaMo, a non-standard analysis method, identifies new modifications in metabolic pathways in LPS and MCAO models of gliosis
- Author
-
G. Felici, G. Mavelli, A. M. Colangelo, M. Papa, L. Alberghina, and P. Bertolazzi
- Subjects
over- or under-expressed genes ,astrogliosis ,gene expression ,metabolic pathways - Abstract
Astrogliosis has been recently investigated to identify genes that are over- or under-expressed and to derive the biological processes involved. In this line of research, we have considered a data set of gene expression in the neuroinflammation model induced by LPS and the ischemic stroke model (MCAO) (Zamanian et al., 2012), where standard biclustering methods fail to attribute a relevant role to the main metabolic pathways in separating models from controls. We analyze this data using DiVaMo, a method inspired by a covering-based feature selection approach (see Bertolazzi et al., 2016). The method identifies group of genes based on their integrated capability to differentiate between model and control samples, based on the expression ratios between models and controls. A single threshold allows a very straightforward control of the sensitivity and the robustness of the results. The separation power of a set is thus derived as a non-additive measure of the power of its genes; application to metabolism-related pathways (Glu/GABA, Glycolysis, TCA Cycle, PPP cycle, Lipid metabolism, NGF-TrkA/p75) identifies those that are significant for one of the two models, or for both.
- Published
- 2016
3. Probing Control Mechanisms of Cell Cycle and Ageing in Budding Yeast
- Author
-
M. Vai, L. Alberghina, M. Vanoni, Alberghina, L, Vai, M, and Vanoni, M
- Subjects
cell cycle, aging, system biology, Saccharomyces cerevisiae ,Ageing ,Genetics ,Biology ,Cell cycle ,BIO/11 - BIOLOGIA MOLECOLARE ,Budding yeast ,Genetics (clinical) ,Cell biology - Abstract
A modular systems biology approach may be useful to gain a better understanding of complex cellular processes, such as cell cycle and ageing. We show in fact in this review that this approach has been successfully applied to the identification of the long sought molecular mechanism able to set the critical cell size required to enter S phase in budding yeast. It involves two sequential thresholds set by the cyclin dependent kinase inhibitors Far1 and Sic1, that cooperate in carbon source modulation of the critical cell size required to enter S phase, a hallmark of response of the cell cycle to changing growth conditions. After this initial validation, the approach is tested to extract from available literature data a blueprint of ageing in budding yeast. The blueprint newly proposes that the process of ageing is initiated at the level of the yeast cell wall, due to the increase in size of ageing mother cells. This event would result in a mechanical stress of the cell wall that generates a signaling response able to activate two interconnected major cellular responses involved in ageing: stress metabolism and chromatin remodelling. The ensuing new approach to ageing studies is described in comparison with current theories of cell ageing. © 2004 Bentham Science Publishers Ltd.
- Published
- 2004
- Full Text
- View/download PDF
4. Computational Strategies for a System-Level Understanding of Metabolism
- Author
-
P. Cazzaniga, C. Damiani, D. Besozzi, R. Colombo, M.S. Nobile, D. Gaglio, D. Pescini, S. Molinari, G. Mauri, L. Alberghina, M, Vanoni, Cazzaniga, P, Damiani, C, Besozzi, D, Colombo, R, Nobile, M, Gaglio, D, Pescini, D, Molinari, S, Mauri, G, Alberghina, L, and Vanoni, M
- Subjects
Reverse engineering ,Computer science ,Endocrinology, Diabetes and Metabolism ,Systems biology ,Metabolism ,metabolome ,modeling ,systems biology ,genome-wide model ,constraint-based model ,core model ,mechanistic model ,ensemble modeling ,parameter estimation ,reverse engineering ,flux balance analysis ,network analysis ,sensitivity analysis ,control theory ,lcsh:QR1-502 ,Inference ,Review ,computer.software_genre ,Biochemistry ,lcsh:Microbiology ,network analysi ,Molecular Biology ,Settore INF/01 - Informatica ,Scale (chemistry) ,INF/01 - INFORMATICA ,sensitivity analysi ,Data science ,BIO/10 - BIOCHIMICA ,flux balance analysi ,System dynamics ,Flux balance analysis ,Identification (information) ,Cell metabolism ,ComputingMethodologies_PATTERNRECOGNITION ,Biochemical engineering ,computer ,metabolism - Abstract
Cell metabolism is the biochemical machinery that provides energy and building blocks to sustain life. Understanding its fine regulation is of pivotal relevance in several fields, from metabolic engineering applications to the treatment of metabolic disorders and cancer. Sophisticated computational approaches are needed to unravel the complexity of metabolism. To this aim, a plethora of methods have been developed, yet it is generally hard to identify which computational strategy is most suited for the investigation of a specific aspect of metabolism. This review provides an up-to-date description of the computational methods available for the analysis of metabolic pathways, discussing their main advantages and drawbacks. In particular, attention is devoted to the identification of the appropriate scale and level of accuracy in the reconstruction of metabolic networks, and to the inference of model structure and parameters, especially when dealing with a shortage of experimental measurements. The choice of the proper computational methods to derive in silico data is then addressed, including topological analyses, constraint-based modeling and simulation of the system dynamics. A description of some computational approaches to gain new biological knowledge or to formulate hypotheses is finally provided.
- Published
- 2014
- Full Text
- View/download PDF
5. Redox control of glutamine utilization in cancer
- Author
-
L Alberghina, 1, 2, D Gaglio1, and 3
- Subjects
Cancer Research ,Glutamine ,Immunology ,Antineoplastic Agents ,Review ,Biology ,Pentose phosphate pathway ,Redox ,NADP Transhydrogenase, AB-Specific ,Serine ,Mitochondrial Proteins ,Pentose Phosphate Pathway ,Cellular and Molecular Neuroscience ,Neoplasms ,Humans ,Glycolysis ,Amino Acids ,Lipid metabolism ,Cell Biology ,NAD ,Lipids ,3. Good health ,Mitochondria ,Biochemistry ,Cancer cell ,NAD+ kinase ,Reactive Oxygen Species ,Oxidation-Reduction ,NADP - Abstract
Glutamine utilization promotes enhanced growth of cancer cells. We propose a new concept map of cancer metabolism in which mitochondrial NADH and NADPH, in the presence of a dysfunctional electron transfer chain, promote reductive carboxylation from glutamine. We also discuss why nicotinamide nucleotide transhydrogenase (NNT) is required in vivo for glutamine utilization by reductive carboxylation. Moreover, NADPH, generated by both the pentose phosphate pathway and the cancer-specific serine glycolytic diversion, appears to sustain glutamine utilization for amino-acid synthesis, lipid synthesis, and for ROS quenching. The fact that the supply of NAD+ precursors reduces tumor aggressiveness suggests experimental approaches to clarify the role of the NADH-driven redox network in cancer.
- Published
- 2014
- Full Text
- View/download PDF
6. Remodelling of supraspinal neuroglial network in neuropathic pain is featured by a reactive gliosis of the nociceptive amygdala
- Author
-
L, Marcello, C, Cavaliere, A M, Colangelo, M R, Bianco, G, Cirillo, L, Alberghina, M, Papa, Marcello, L, Cavaliere, C, Colangelo, A, Bianco, M, Cirillo, G, Alberghina, L, Papa, M, Colangelo, Am, Bianco, Mr, and Papa, Michele
- Subjects
Male ,synaptic plasticity ,NGF-like peptide ,Amygdala ,BIO/10 - BIOCHIMICA ,Rats ,Rats, Sprague-Dawley ,Disease Models, Animal ,Spinal Cord ,Animals ,Neuralgia ,peripheral nerve injury ,Gliosis ,Neuroglia - Abstract
Background: Many brain areas participate to supraspinal control of nociception. In these regions, few studies have investigated the role of glial cells in supraspinal plasticity and the effect of 7-day intrathecal nerve growth factor-like (BB14®, Blueprint Biotech, Milano, Italy) treatment. Methods: In male Sprague-Dawley rats, we evaluated by immunohistochemistry the morphological and molecular rearrangement of neuroglial network occurring in several supraspinal brain regions involved in pain processing following spared nerve injury (SNI) of the sciatic nerve. In particular, the medial prefrontal cortex, the amygdala (Amy), the nucleus accumbens (Acb), the thalamus and the periaqueductal gray were analysed. Results: Despite the modifications occurring in the dorsal horn of spinal cord following SNI, no significant changes in the Iba1 and glial fibrillary acidic protein (GFAP) expression were detected in all the analysed supraspinal regions, except for the Amy, showing a remarkable GFAP increase. Interestingly, neuropathic rats also displayed a significant increase of glial transporters (GTs) in all the supraspinal regions. Finally, the analysis of vesicular glutamate transporter 1 (vGLUT1) and vesicular gamma-aminobutyric acid (GABA) transporter (vGAT) expression revealed a significant enhancement of glutamatergic/GABAergic ratio in all selected brain regions of SNI animals, except for Acb. Both glial activation in the Amy and alteration of GTs and vGLUT/vGAT levels observed in neuropathic animals were largely reversed by BB14® treatment. Conclusions: All together, these data strengthen the role of supraspinal neuroglial network plasticity in the establishment of neuropathic pain syndrome. The hallmark is represented by the divergence between glial reaction confined to Amy and the widespread changes in the GT distribution and glutamate/GABA ratio detected in the other supraspinal region.
- Published
- 2013
7. The Minimal Active Domain of the Mouse Ras Exchange Factor CDC25Mm
- Author
-
Enzo Martegani, I. Mauri, Paola Coccetti, L. Alberghina, Andrea Parmeggiani, Coccetti, P, Mauri, I, Alberghina, L, Martegani, E, and Parmeggiani, A
- Subjects
Saccharomyces cerevisiae Proteins ,GTP' ,Cdc25 ,Restriction Mapping ,Protein domain ,Biophysics ,Cell Cycle Proteins ,Saccharomyces cerevisiae ,Biology ,Guanosine Diphosphate ,Polymerase Chain Reaction ,Biochemistry ,Fungal Proteins ,Proto-Oncogene Proteins p21(ras) ,Mice ,Structure-Activity Relationship ,GEF, CDc25Mm, Saccharomyces cerevisiae, Ras ,In vivo ,Animals ,Guanine Nucleotide Exchange Factors ,Molecular Biology ,chemistry.chemical_classification ,ras-GRF1 ,Genetic Complementation Test ,Proteins ,Biological activity ,Cell Biology ,BIO/11 - BIOLOGIA MOLECOLARE ,BIO/10 - BIOCHIMICA ,Yeast ,In vitro ,Amino acid ,Kinetics ,chemistry ,Mutagenesis ,biology.protein ,ras Guanine Nucleotide Exchange Factors ,Gene Deletion ,Plasmids - Abstract
The minimal active domain of the mouse CDC25Mm, a GDP/GTP exchange factor (GEF) active on H-ras protein, was determined by constructing several deletion mutants of the C-terminal domain of the protein. The functional activity of these fragments was analyzed for the ability to complement the yeast temperature sensitive mutation cdc25-1 and to catalyze the GDP/GTP exchange on Ras proteins in vitro. A C-terminal domain of 256 residues (CDC25 Mm1005-1260) was sufficient for full biological activity in vivo. Deletion of 27 C-terminal amino acids (CDC25 Mm1005-1233) abolished the complementing activity while deletion of 25 N-terminal residues (CDC25Mm1030-1260 corresponding to the most conserved domain) led to a complete loss of expression. The results in vivo were supported by experiments in vitro. Highly purified CDC25Mm1005-1260, expressed in E. coli using the pMAL system, enhanced the GDP release from both H-ras p21 and S. cerevisiae Ras2p and its activity was nearly as high as that of CDC25Mm974-1260. Comparison with the Cdc25p protein yielded further evidence that the minimal active domain of CDC25Mm is shorter than the yeast one. © 1995 Academic Press, Inc.
- Published
- 1995
- Full Text
- View/download PDF
8. A Deterministic Model Describing IntraMolecular Regulation of hSos1, the Major Activator of the ProtoOncoprotein Ras
- Author
-
E. Sacco, M. Farina, C. Greco, S. Busti, C. Conz, S. Lamperti, L. DeGioia, D. Liberati, L. Alberghina, and M. Vanoni
- Subjects
Systems Biology - Abstract
The multi-domain protein hSos1 plays a major role in cell growth and differentiation through its Ras-specific guanine nucleotide exchange domain whose complex regulation involves intra-molecular, inter-domain rearrangements. We present a stochastic mathematical model describing intra-molecular regulation of hSos1 activity. The population macroscopic effect is reproduced through a Monte-Carlo approach. Key model parameters have been experimentally determined by BIAcore analysis. Complementation experiments of a Saccharomyces cerevisiae cdc25(ts) strain with Sos deletion mutants provided a comprehensive data set for estimation of unknown parameters and model validation. The model is robust against parameter alteration and describes both the behavior of Sos deletion mutants and modulation of activity of the full length molecule under physiological conditions. By incorporating the calculated effect of aminoacid changes at an inter-domain interface, the behavior of a mutant correlating with a developmental syndrome could be simulated, further validating the model. The activation state of Ras-specific guanine nucleotide exchange domain of hSos1 arises as an "emergent property" of its multi-domain structure that allows multi-level integration of a complex network of intra- and inter-molecular signals.
- Published
- 2011
9. Regulation of hSos1 activity is a system-level property generated by its multi-domain structure
- Author
-
E. Sacco, M. Farina, C. Greco, S. Busti, L. de Gioia, D. Liberati, L. Alberghina, and M. Vanoni
- Subjects
Systems Biology - Published
- 2010
10. A deterministic model describing intra-molecular regulation of hSos1, the major activator of the proto-oncoprotein Ras
- Author
-
E. Sacco, M. Farina, C. Greco, S. Busti, C. Conz, S. Lamperti, L. De Gioia, D. Liberati, L. Alberghina, and M. Vanoni
- Subjects
Systems Biology - Published
- 2010
11. Transcriptional Profiling of Normal and Transformed Fibroblasts: Effect of Growth Under Limiting Glucose Concentration
- Author
-
C. Balestrieri, F. Chiaradonna, D. Liberati, M. Vanoni, and L. Alberghina
- Published
- 2008
12. Molecular and computational analysis of regulation of hSos1, the major activator of the proto-oncoprotein Ras
- Author
-
E. Sacco, M. Farina, C. Greco, S. Busti, L. De Gioia, S. Fantinato, D. Liberati, L. Alberghina, and M. Vanoni
- Subjects
AUT - Published
- 2007
13. Molecular evolution of the Molecular evolution of the neurotrophin family members and their Trk receptors
- Author
-
Lanave, Colangelo, A.M., Saccone C., and L. Alberghina.
- Subjects
nervous system - Abstract
The study of the mechanisms underlying the coevolution processes of these gene families and how they correlate with the increased complexity of the vertebrate nervous system. In order to improve our current knowledge of the molecular evolution of neurotrophins and receptors, we have collected all information available in the literature and analyzed the genome database for each of them. Statistical analysis of aminoacid and nucleotide sequences of the neurotrophin and Trk family genes was applied to both complete genes and mature sequences, and different phylogenetic methods were used to compare aminoacid and nucleotide sequences variability among the different species. All collected data favor a model in which several rounds of genome duplications might have facilitated the generation of the many different neurotrophins and the acquisition of specific different functions correlated with the increased complexity of the vertebrate nervous system during evolution. We report findings that refine the structure of the evolutionary trees for neurotrophins and Trk receptors families, indicate different rates of evolution for each member of the two families.
- Published
- 2007
14. The Importance of a Correct Diet in Preventing Osteoporosis
- Author
-
Testa G, Pavone V, primary and Lucenti L, Alberghina F, additional
- Published
- 2015
- Full Text
- View/download PDF
15. Cloning, sequencing, and expression of Candida rugosa lipases
- Author
-
L, Alberghina and M, Lotti
- Subjects
Base Sequence ,Sequence Homology, Amino Acid ,Molecular Sequence Data ,Restriction Mapping ,Chromosome Mapping ,Lipase ,Recombinant Proteins ,Isoenzymes ,Species Specificity ,Multigene Family ,Amino Acid Sequence ,Chromosomes, Fungal ,Cloning, Molecular ,Genome, Fungal ,Sequence Alignment ,Candida - Published
- 1997
16. Repression of growth-regulated G1 cyclin expression by cyclic AMP in budding yeast
- Author
-
M D, Baroni, P, Monti, and L, Alberghina
- Subjects
Transformation, Genetic ,Cyclins ,Gene Expression Regulation, Fungal ,Cyclic AMP ,G1 Phase ,Saccharomyces cerevisiae ,Cell Division ,Signal Transduction - Abstract
A yeast cell becomes committed to the cell division cycle only if it grows to a critical size and reaches a critical rate of protein synthesis. The coordination between growth and division takes place at a control step during the G1 phase of the cell cycle called Start. It relies on the G1-specific cyclins encoded by CLN1, 2 and 3, which trigger Start through the activation of the Cdc28 protein kinase. In fact, the Cln cyclins are rate-limiting for Start execution and depend on growth. Here we report that the cyclic AMP signal pathway modulates the dependency of Cln cyclins on growth. In particular, more growth is required to trigger Start because CLN1 and CLN2 are repressed by the cAMP signal, thus explaining the previously observed cAMP-dependent increase of the critical size and critical rate of protein synthesis. Cln3 is not inhibited by the cAMP pathway and counteracts this mechanism by partially mediating the growth-dependent expression of other G1 cyclins.
- Published
- 1994
17. Cell cycle and growth regulation in RAS2 mutant cells of Saccharomyces cerevisiae
- Author
-
M D, Baroni, G, Marconi, P, Monti, and L, Alberghina
- Subjects
Fungal Proteins ,Saccharomyces cerevisiae Proteins ,RNA, Ribosomal ,Cell Cycle ,Mutation ,Cyclic AMP ,Temperature ,ras Proteins ,Saccharomyces cerevisiae - Abstract
Yeast cells carrying ras2 temperature-sensitive mutations undergo a specific arrest in the prereplicative unbudded phase of the cell cycle when they are shifted to non-permissive temperatures. At 36.5 degrees C, in spite of their abnormally large cell size, bulk protein synthesis and accumulation rates are depressed in ras2 temperature-sensitive cells in comparison with isogenic wild type. At the same temperature, total RNA synthesis and accumulation rates are much more inhibited, suggesting that a defective Ras2/cAMP pathway alters the coordination between RNA and protein synthesis rates. The preferential RNA synthesis inhibition is correlated to a specific inhibition of the synthesis of the 35S rRNA precursor. These findings, taken together with the results of previous analyses, are in favour of a control by the cAMP pathway on rRNA biosynthesis.
- Published
- 1993
18. Towards a Yeast Cell Cycle Hybrid Model: Structural Characterization of Recombinant Whi5, a Transcriptional Regulator of Cycle Progression in Saccharomyces cerevisiae
- Author
-
A.M. Trillo, S. Brocca, and L. Alberghina
- Subjects
Cyclin-dependent kinase 1 ,biology ,Saccharomyces cerevisiae ,Bioengineering ,General Medicine ,biology.organism_classification ,Applied Microbiology and Biotechnology ,Cell biology ,law.invention ,Yeast cell cycle ,law ,Transcriptional regulation ,Recombinant DNA ,Hybrid model ,Cycle progression ,Biotechnology - Published
- 2010
- Full Text
- View/download PDF
19. Analysis of the respiratory activity in growing budding yeast by flow cytometric procedures.
- Author
-
L. Alberghina, L. Frontali and P. Sensi Elsevier, Amsterdam, London, New York, Tokyo, Part II, 577-580, 1994., Porro, D, Smeraldi, C, Ranzi, B, Martegani, E, Alberghina, L, PORRO, DANILO, Ranzi, BM, ALBERGHINA, LILIA, L. Alberghina, L. Frontali and P. Sensi Elsevier, Amsterdam, London, New York, Tokyo, Part II, 577-580, 1994., Porro, D, Smeraldi, C, Ranzi, B, Martegani, E, Alberghina, L, PORRO, DANILO, Ranzi, BM, and ALBERGHINA, LILIA
- Published
- 1994
20. Use of recombinant Saccharomyces cerevisiae cells for the utilization of agro-industrial wastes.
- Author
-
L. Alberghina, L. Frontali and P. Sensi, Martegani, E, Compagno, C, Porro, D, Tura, A, Brambilla, L, Vanoni, M, Ranzi, B, Alberghina, L, MARTEGANI, ENZO, PORRO, DANILO, BRAMBILLA, LUCA GIUSEPPE, VANONI, MARCO ERCOLE, ALBERGHINA, LILIA, Ranzi, BM, L. Alberghina, L. Frontali and P. Sensi, Martegani, E, Compagno, C, Porro, D, Tura, A, Brambilla, L, Vanoni, M, Ranzi, B, Alberghina, L, MARTEGANI, ENZO, PORRO, DANILO, BRAMBILLA, LUCA GIUSEPPE, VANONI, MARCO ERCOLE, ALBERGHINA, LILIA, and Ranzi, BM
- Published
- 1994
21. The Yeast Genome Directory
- Author
-
A. Goffeau, R. Aert, M. L. Agostini-Carbone, A. Ahmed, M. Aigle, L. Alberghina, K. Albermann, M. Albers, M. Aldea, D. Alexandraki, G. Aljinovic, E. Allen, J. Alt-Mörbe, B. André, S. Andrews, W. Ansorge, G. Antoine, R. Anwar, A. Aparicio, R. Araujo, J. Arino, F. Arnold, J. Arroyo, E. Aviles, U. Backes, M. C. Baclet, K. Badcock, A. Bahr, V. Baladron, J. P. G. Ballesta, A. T. Bankier, A. Banrevi, M. Bargues, L. Baron, T. Barreiros, B. G. Barrell, C. Barthe, A. B. Barton, A. Baur, A.-M. Bécam, A. Becker, I. Becker, J. Beinhauer, V. Benes, P. Benit, G. Berben, E. Bergantino, P. Bergez, A. Berno, I. Bertani, N. Biteau, A. J. Bjourson, H. Blöcker, C. Blugeon, C. Bohn, E. Boles, P. A. Bolle, M. Bolotin-Fukuhara, R. Bordonné, J. Boskovic, P. Bossier, D. Botstein, G. Bou, S. Bowman, J. Boyer, P. Brandt, T. Brandt, M. Brendel, T. Brennan, R. Brinkman, A. Brown, A. J. P. Brown, D. Brown, M. Brückner, C. V. Bruschi, J. M. Buhler, M. J. Buitrago, F. Bussereau, H. Bussey, A. Camasses, C. Carcano, G. Carignani, J. Carpenter, A. Casamayor, C. Casas, L. Castagnoli, H. Cederberg, E. Cerdan, N. Chalwatzis, R. Chanet, E. Chen, G. Chéret, J. M. Cherry, T. Chillingworth, C. Christiansen, J.-C. Chuat, E. Chung, C. Churcher, C. M. Churcher, M. W. Clark, M. L. Clemente, A. Coblenz, M. Coglievina, E. Coissac, L. Colleaux, R. Connor, R. Contreras, J. Cooper, T. Copsey, F. Coster, R. Coster, J. Couch, M. Crouzet, C. Cziepluch, B. Daignan-Fornier, F. Dal Paro, D. V. Dang, M. D’Angelo, C. J. Davies, K. Davis, R. W. Davis, A. De Antoni, S. Dear, K. Dedman, E. Defoor, M. De Haan, Th. Delaveau, S. Del Bino, M. Delgado, H. Delius, D. Delneri, F. Del Rey, J. Demolder, N. Démolis, K. Devlin, P. de Wergifosse, F. S. Dietrich, H. Ding, C. Dion, T. Dipaolo, F. Doignon, C. Doira, H. Domdey, J. Dover, Z. Du, E. Dubois, B. Dujon, M. Duncan, P. Durand, A. Düsterhöft, S. Düsterhus, T. Eki, M. El Bakkoury, L. G. Eide, K.-D. Entian, P. Eraso, D. Erdmann, H. Erfle, V. Escribano, M. Esteban, L. Fabiani, F. Fabre, C. Fairhead, B. Fartmann, A. Favello, G. Faye, H. Feldmann, L. Fernandes, F. Feroli, M. Feuermann, T. Fiedler, W. Fiers, U. N. Fleig, M. Flöth, G. M. Fobo, N. Fortin, F. Foury, M. C. Francingues-Gaillard, L. Franco, A. Fraser, J.D. Friesen, C. Fritz, L. Frontali, H. Fukuhara, L. Fulton, L. J. Fuller, C. Gabel, C. Gaillardin, L. Gaillon, F. Galibert, F. Galisson, P. Galland, F.-J. Gamo, C. Gancedo, J. M. Garcia-Cantalejo, M. I. García-Gonzalez, J. J. Garcia-Ramirez, M. García-Saéz, H. Gassenhuber, M. Gatius, S. Gattung, C. Geisel, M. E. Gent, S. Gentles, M. Ghazvini, D. Gigot, V. Gilliquet, N. Glansdorff, A. Gómez-Peris, A. Gonzaléz, S. E. Goulding, C. Granotier, T. Greco, M. Grenson, P. Grisanti, L. A. Grivell, D. Grothues, U. Gueldener, P. Guerreiro, E. Guzman, M. Haasemann, B. Habbig, H. Hagiwara, J. Hall, K. Hallsworth, N. Hamlin, N. J. Hand, V. Hanemann, J. Hani, T. Hankeln, M. Hansen, D. Harris, D. E. Harris, G. Hartzell, D. Hatat, U. Hattenhorst, J. Hawkins, U. Hebling, J. Hegemann, C. Hein, A. Hennemann, K. Hennessy, C. J. Herbert, K. Hernandez, Y. Hernando, E. Herrero, K. Heumann, D. Heuss- Neitzel, N. Hewitt, R. Hiesel, H. Hilbert, F. Hilger, L. Hillier, C. Ho, J. Hoenicka, B. Hofmann, J. Hoheisel, S. Hohmann, C. P. Hollenberg, K. Holmstrøm, O. Horaitis, T. S. Horsnell, M.-E. Huang, B. Hughes, S. Hunicke-Smith, S. Hunt, S. E. Hunt, K. Huse, R. W. Hyman, F. Iborra, K. J. Indge, I. Iraqui Houssaini, K. Isono, C. Jacq, M. Jacquet, A. Jacquier, K. Jagels, W. Jäger, C. M. James, J. C. Jauniaux, Y. Jia, M. Jier, A. Jimenez, D. Johnson, L. Johnston, M. Johnston, M. Jones, J.-L. Jonniaux, D. B. Kaback, T. Kallesøe, S. Kalman, A. Kalogeropoulos, L. Karpfinger-Hartl, D. Kashkari, C. Katsoulou, A. Kayser, A. Kelly, T. Keng, H. Keuchel, P. Kiesau, L. Kirchrath, J. Kirsten, K. Kleine, U. Kleinhans, R. Klima, C. Komp, E. Kordes, S. Korol, P. Kötter, C. Krämer, B. Kramer, P. Kreisl, T. Kucaba, H. Kuester, O. Kurdi, P. Laamanen, M. J. Lafuente, O. Landt, G. Lanfranchi, Y. Langston, D. Lashkari, P. Latreille, G. Lauquin, T. Le, P. Legrain, Y. Legros, A. Lepingle, H. Lesveque, H. Leuther, H. Lew, C. Lewis, Z. Y. Li, S. Liebl, A. Lin, D. Lin, M. Logghe, A. J. E. Lohan, E. J. Louis, G. Lucchini, K. Lutzenkirchen, R. Lyck, G. Lye, A. C. Maarse, M. J. Maat, C. Macri, A. Madania, M. Maftahi, A. Maia e Silva, E. Maillier, L. Mallet, G. Mannhaupt, V. Manus, R. Marathe, C. Marck, A. Marconi, E. Mardis, E. Martegani, R. Martin, A. Mathieu, C. T. C. Maurer, M. J. Mazón, C. Mazzoni, D. McConnell, S. McDonald, R. A. McKee, A. D. K. McReynolds, P. Melchioretto, S. Menezes, F. Messenguy, H. W. Mewes, G. Michaux, N. Miller, O. Minenkova, T. Miosga, S. Mirtipati, S. Möller-Rieker, D. Möstl, F. Molemans, A. Monnet, A-L. Monnier, M. A. Montague, M. Moro, D. Mosedale, S. Moule, L. Mouser, Y. Murakami, S. Müller-Auer, J. Mulligan, L. Murphy, M. Muzi Falconi, M. Naitou, K. Nakahara, A. Namath, F. Nasr, L. Navas, A. Nawrocki, J. Nelson, U. Nentwich, P. Netter, R. Neu, C. S. Newlon, M. Nhan, J.-M. Nicaud, R. K. Niedenthal, C. Nombela, D. Noone, R. Norgren, B. Nußbaumer, B. Obermaier, C. Odell, P. Öfner, C. Oh, K. Oliver, S. G. Oliver, B. F. Ouellette, M. Ozawa, V. Paces, C. Pallier, D. Pandolfo, L. Panzeri, S. Paoluzi, A. G. Parle-Mcdermott, S. Pascolo, N. Patricio, A. Pauley, L. Paulin, B. M. Pearson, D. Pearson, D. Peluso, J. Perea, M. Pérez-Alonso, J. E. Pérez-Ortin, A. Perrin, F. X. Petel, B. Pettersson, F. Pfeiffer, P. Philippsen, A. Piérard, E. Piravandi, R. J. Planta, P. Plevani, O. Poch, B. Poetsch, F. M. Pohl, T. M. Pohl, R. Pöhlmann, R. Poirey, D. Portetelle, F. Portillo, S. Potier, M. Proft, H. Prydz, A. Pujol, B. Purnelle, V. Puzos, M. A. Rajandream, M. Ramezani Rad, S. W. Rasmussen, A. Raynal, S. Rechmann, M. Remacha, J. L. Revuelta, P. Rice, G-F. Richard, P. Richterich, M. Rieger, L. Rifken, L. Riles, T. Rinaldi, M. Rinke, A. B. Roberts, D. Roberts, F. Rodriguez, E. Rodriguez-Belmonte, C. Rodriguez-Pousada, A. M. Rodriguez-Torres, M. Rose, R. Rossau, N. Rowley, T. Rupp, M. Ruzzi, W. Saeger, J. E. Saiz, M. Saliola, D. Salom, H. P. Saluz, M. Sánchez-Perez, M. A. Santos, E. Sanz, J. E. Sanz, A.-M. Saren, F. Sartorello, M. Sasanuma, S-I. Sasanuma, T. Scarcez, I. Schaaf-Gerstenschläger, B. Schäfer, M. Schäfer, M. Scharfe, B. Scherens, N. Schroff, M. Sen-Gupta, T. Shibata, T. Schmidheini, E. R. Schmidt, C. Schneider, P. Scholler, S. Schramm, A. Schreer, M. Schröder, C. Schwager, S. Schwarz, C. Schwarzlose, B. Schweitzer, M. Schweizer, A-M. Sdicu, P. Sehl, C. Sensen, J. G. Sgouros, T. Shogren, L. Shore, Y. Shu, J. Skala, J. Skelton, P. P. Slonimski, P. H. M. Smit, V. Smith, H. Soares, E. Soeda, A. Soler-Mira, F. Sor, N. Soriano, J. L. Souciet, C. Soustelle, R. Spiegelberg, L. I. Stateva, H. Y. Steensma, J. Stegemann, S. Steiner, L. Stellyes, F. Sterky, R. K. Storms, H. St. Peter, R. Stucka, A. Taich, E. Talla, I. Tarassov, H. Tashiro, P. Taylor, C. Teodoru, H. Tettelin, A. Thierry, G. Thireos, E. Tobiasch, D. Tovan, E. Trevaskis, Y. Tsuchiya, M. Tzermia, M. Uhlen, A. Underwood, M. Unseld, J. H. M. Urbanus, A. Urrestarazu, S. Ushinsky, M. Valens, G. Valle, A. Van Broekhoven, M. Vandenbol, Q. J. M. Van Der Aart, C. G. Van Der Linden, L. Van Dyck, M. Vanoni, J. C. Van Vliet-Reedijk, A. Vassarotti, M. Vaudin, K. Vaughan, P. Verhasselt, I. Vetter, F. Vierendeels, D. Vignati, C. Vilela, S. Vissers, C. Vleck, D. T. Vo, D. H. Vo, M. Voet, G. Volckaert, D. Von Wettstein, H. Voss, P. Vreken, G. Wagner, S. V. Walsh, R. Wambutt, H. Wang, Y. Wang, J. R. Warmington, R. Waterston, M. D. Watson, N. Weber, E. Wedler, H. Wedler, Y. Wei, S. Whitehead, B. L. Wicksteed, S. Wiemann, L. Wilcox, C. Wilson, R. Wilson, A. Winant, E. Winnett, B. Winsor, P. Wipfli, S. Wölfl, P. Wohldman, K. Wolf, K. H. Wolfe, L. F. Wright, H. Wurst, G. Xu, M. Yamasaki, M. A. Yelton, K. Yokohama, A. Yoshikawa, S. Yuping, P. Zaccaria, M. Zagulski, F. K. Zimmermann, J. Zimmermann, M. Zimmermann, W-W. Zhong, A. Zollner, and E. Zumstein
- Subjects
Multidisciplinary ,Computational biology ,Directory ,Biology ,Yeast genome - Published
- 1997
- Full Text
- View/download PDF
22. Mathematical Modelling of Cell Growth and Proliferation
- Author
-
Enzo Martegani, L. Alberghina, and Luigi Mariani
- Subjects
education.field_of_study ,Mathematical model ,Cell growth ,Population ,Cell ,General Medicine ,Cell cycle ,Biology ,Yeast ,Cell size ,Cell biology ,Transformed cell ,medicine.anatomical_structure ,medicine ,education ,Biological system - Abstract
Models able to describe the events of cellular growth and division and the dynamics of cell populations are useful for the understanding of control mechanisms and for theoretical support for the automated analysis of flow cytometric data and of cell volume distributions. This paper reports on models that have been developed by the Authors with this aim, describing in a rather unitary frame the cell cycle of eukaryotic cells, like mammalian cells and yeast, and of prokaryotic cells. The model is based on the assumption that the progression of the nuclear division cycle is regulated by a sequential attainment of two threshold protein levels. It accounts for a number of features of cell growth and division in population of actively growing cells, it explains all the different patterns of cell cycle which are experimentally found and yields quantitative relations between timing of the cell cycle and macromolecular composition of the cells. The model is also used to study the effect of various sources of variability on the statistical properties of cell populations and the main source of variability appears to be an inaccuracy of the molecular mechanism that monitors the cell size. Besides in normal mammalian cells a second source of variability is apparent, which depends upon the interaction with growth factors which give competence. An extended version of the model, which comprises also this additional variability, is also considered and used to describe properties of normal and transformed cell growth.
- Published
- 1988
- Full Text
- View/download PDF
23. Control of the yeast cell cycle by protein synthesis
- Author
-
L, Popolo, M, Vanoni, L, Alberghina, Popolo, L, Vanoni, M, and Alberghina, L
- Subjects
Protein Biosynthesi ,RNA, Ribosomal ,Protein Biosynthesis ,Cell Cycle ,Saccharomyces cerevisiae ,Cycloheximide ,BIO/10 - BIOCHIMICA - Abstract
The increased synthesis of ribosomal RNA (rRNA) is correlated with enhanced cell proliferation, and it has been suggested that rRNA metabolism may have a regulatory role in the progression of the cell cycle. Alternatively, it might be the ensuing more active protein synthesis that drives the cell cycle progression. We have found that treatment with low doses of cycloheximide dissociates rRNA and protein synthesis. In fact, after the addition of cycloheximide the protein synthesis rate is strongly inhibited, whereas the rate of rRNA synthesis is unaffected for some time. The progression of the cell cycle, monitored as analysis of DNA distribution by flow cytometry and as bud emergence, is quickly and largely inhibited, thus indicating that a sustained rRNA metabolism is not sufficient to allow continuous cycle progression. The effects of cycloheximide on the daughter and mother duplication times, on the mean cell volume, and on the volume at budding were also analyzed. The results suggest that protein synthesis, rather than rRNA synthesis, may have a key role in the control of cell cycle progression in Saccharomyces cerevisiae.
- Published
- 1982
24. Modeling Neurospora growth
- Author
-
L. Alberghina and E. Martegani
- Subjects
Biochemistry ,Biology ,biology.organism_classification ,Neurospora - Published
- 1977
- Full Text
- View/download PDF
25. Evolutionary origin of nonuniversal CUG(Ser) codon in some Candida species as inferred from a molecular phylogeny
- Author
-
Cecilia Saccone, Graziano Pesole, L Alberghina, Marina Lotti, Pesole, G, Lotti, M, Alberghina, L, and Saccone, C
- Subjects
RNA, Transfer, Leu ,Genes, Fungal ,Molecular Sequence Data ,Sequence alignment ,Biology ,Investigations ,DNA, Ribosomal ,Evolution, Molecular ,Monophyly ,Ascomycota ,Species Specificity ,Phylogenetics ,Sequence Homology, Nucleic Acid ,Genetics ,RNA, Ribosomal, 18S ,Serine ,DNA, Fungal ,Codon ,RNA, Transfer, Ser ,Phylogeny ,Candida ,Phylogenetic tree ,Base Sequence ,RNA, Fungal ,Genetic code ,biology.organism_classification ,Genetic Code ,Transfer RNA ,Molecular phylogenetics ,Sequence Alignment - Abstract
CUG, a universal leucine codon, has been reported to be read as serine in various yeast species belonging to the genus Candida. To gain a deeper insight into the origin of this deviation from the universal genetic code, we carried out a phylogenetic analysis based on the small-subunit ribosomal RNA genes from some Candida and other related Hemiascomycetes. Furthermore, we determined the phylogenetic relationships between the tRNA(Ser)CAG, responsible for the translation of CUG, from some Candida species and the other serine and leucine isoacceptor tRNAs in C. cylindracea. We demonstrate that the group of Candida showing the genetic code deviation is monophyletic and that this deviation could have originated more than 150 million years ago. We also describe how phylogenetic analysis can be used for genetic code predictions.
26. Control of growth and of the nuclear division cycle in Neurospora crassa
- Author
-
L Alberghina and E Sturani
- Subjects
Fungal protein ,Neurospora crassa ,Cell Cycle ,Temperature ,RNA, Fungal ,Biology ,Cell cycle ,biology.organism_classification ,Applied Microbiology and Biotechnology ,Neurospora ,Models, Biological ,Cell biology ,Fungal Proteins ,Nuclear division ,Botany ,Escherichia coli ,Amino Acids ,DNA, Fungal ,Ribosomes ,Mathematics ,Research Article
27. A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins
- Author
-
Andrea Parmeggiani, C Ferrari, Eric Jacquet, Enzo Martegani, L Alberghina, Marco Vanoni, Jacquet, E, Vanoni, M, Ferrari, C, Alberghina, L, Martegani, E, and Parmeggiani, A
- Subjects
Adenylate Cyclase ,Saccharomyces cerevisiae Proteins ,GTP' ,G protein ,Saccharomyces cerevisiae ,Genes, Fungal ,Rap GTP-binding protein ,Fungal Protein ,Biology ,Biochemistry ,Guanosine Diphosphate ,rap GTP-Binding Protein ,Fungal Proteins ,Proto-Oncogene Proteins p21(ras) ,Mice ,Ras-GRF1 ,GTP-binding protein regulators ,GTP-Binding Proteins ,Animals ,Humans ,Ras2 ,Molecular Biology ,Kinetic ,Animal ,ras-GRF1 ,Cell Membrane ,Proteins ,Cell Biology ,biology.organism_classification ,ras Protein ,enzymes and coenzymes (carbohydrates) ,Kinetics ,rap GTP-Binding Proteins ,ras Proteins ,Guanosine Triphosphate ,biological phenomena, cell phenomena, and immunity ,Saccharomyces cerevisiae Protein ,Adenylyl Cyclases ,Human ,GTP-Binding Protein ,Protein Binding - Abstract
GDP-dissociation stimulators (GDSs) are the key element for the regeneration of the active state of ras proteins, but despite intensive investigations, little is so far known about their functional and structural properties, particularly in mammals. A growing number of genes from various organisms have been postulated to encode GDSs on the basis of sequence similarity with the Saccharomyces cerevisiae CDC25 gene, whose product acts as a GDS of RAS proteins. However, except for CDC25 and the related SDC25 C-domain, no biochemical evidence of ras GDS activity for these CDC25-like proteins has yet been available. We show that the product of a recently isolated mouse CDC25-like gene (CDC25Mm) can strongly enhance (more than 1000 times) the GDP release from both human c-Ha-ras p21 and yeast RAS2 in vitro. As a consequence, the CDC25Mm induces a rapid formation of the biologically active Ras.GTP complex. This GDS is much more active on the GDP than on the GTP complex and has a narrow substrate specificity, since it was found to be inactive on several ras-like proteins. The mouse GDS can efficiently substitute for yeast CDC25 in an in vitro adenylylcyclase assay on RAS2 cdc25 yeast membranes. Our results show that a cloned GDP to GTP exchange factor of mammalian ras belongs to the novel family of CDC25-like proteins.
28. Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells
- Author
-
Alessandra Baracca, Ferdinando Chiaradonna, Lilia Alberghina, Giorgio Lenaz, Gianluca Sgarbi, Giancarlo Solaini, A. Baracca, F. Chiaradonna, G. Sgarbi, G. Solaini, L. Alberghina, G. Lenaz, Baracca, A, Chiaradonna, F, Sgarbi, G, Solaini, G, Alberghina, L, and Lenaz, G
- Subjects
Bioenergetics ,Cellular respiration ,Cell Respiration ,Biophysics ,oncogene, K-ras, trasformation, mitochondria dysfunction ,Oxidative phosphorylation ,Mitochondrion ,Biochemistry ,Oxidative Phosphorylation ,chemistry.chemical_compound ,Mice ,Adenosine Triphosphate ,Animals ,Glycolysis ,Cells, Cultured ,Cell Proliferation ,Oligonucleotide Array Sequence Analysis ,Membrane Potential, Mitochondrial ,Electron Transport Complex I ,ATP synthase ,biology ,Respiration ,Gene Expression Profiling ,ATP SYNTHESIS ,Cell Biology ,Fibroblasts ,BIO/10 - BIOCHIMICA ,CANCER ,Cell biology ,Mitochondria ,Oxygen ,Cell Transformation, Neoplastic ,Genes, ras ,chemistry ,Cancer cell ,biology.protein ,COMPLEX I ,Energy Metabolism ,Adenosine triphosphate ,K-RAS ,Oxidation-Reduction ,Biomarkers - Abstract
Many cancer cells are characterized by high rate of glycolysis and reduced rate of aerobic respiration, whose mechanism is still elusive. Here we investigate the down-regulation of oxidative phosphorylation (OXPHOS) in K-ras transformed mouse fibroblasts as compared to a control counterpart. Transcriptional analysis showed different expression levels of several OXPHOS nuclear genes in the two cell lines. In particular, during the exponential growth phase most genes encoding proteins of Complex I were expressed at lower levels in transformed cells. Consistently, a significant decrease of Complex I content was found in transformed cells. Moreover, analysis of NAD-dependent respiration and ATP synthesis indicated a strong decrease of Complex I activity in the mitochondria from neoplastic cells, that was confirmed by direct assay of the enzyme redox activity. At variance, succinate-dependent respiration and ATP synthesis were not significantly affected. Taken together, our results provide the new insight that the reduction of respiration observed in K-ras transformed cells is specifically due to a Complex I activity decrease.
- Published
- 2009
29. Characterisation of the supramolecular organisation of the mitochondrial respiratory chain: a methodological approach by Metabolic Control Analysis
- Author
-
GENOVA, MARIA LUISA, BARBERO, GIOVANNA, DALMONTE, MARIA ELENA, FACCIOLI, MARCO, LENAZ, GIORGIO, A. I. Falasca, AUTORI VARI, L. ALBERGHINA, L. MILANESI, M.L. Genova, G. Barbero, M.E. Dalmonte, M. Faccioli, A.I. Falasca, and G. Lenaz
- Subjects
RESPIRATORY CHAIN ,MITOCHONDRIA ,CHANNELLING ,SUPERCOMPLEXES - Abstract
We have exploited metabolic flux control analysis to differentiate between randomly distributed respiratory complexes and substrate channelling in supercomplexes in mitochondria. Blue-native gel electrophoresis shows supercomplexes comprising Complexes I, III and IV in most systems examined, however our flux control studies demonstrated that electron channelling occurs only between Complexes I and III in mammalian mitochondria, whereas Complex IV is functionally distinct and is fed electrons by the pool behaviour of cytochrome c. This is at difference with plant mitochondria where Complexes I, III and IV represent a single functional unit. The stability of supercomplexes is dictated by the lipid content and is strongly decreased by lipid peroxidation.
- Published
- 2009
30. Heterologous production of five Hepatitis C virus-derived antigens in three Saccharomyces cerevisiae host strains
- Author
-
Lilia Alberghina, Paola Branduardi, Carola Eleonora Parolin, Danilo Porro, Andrea Dal Corso, Parolin, C, Corso, A, Alberghina, L, Porro, D, Branduardi, P, C. Parolin, A. Dal Corso, L. Alberghina, D. Porro, and P. Branduardi
- Subjects
Saccharomyces cerevisiae Proteins ,Hepatitis C virus ,Saccharomyces cerevisiae ,Heterologous ,Bioengineering ,medicine.disease_cause ,Protein Engineering ,Transfection ,Applied Microbiology and Biotechnology ,Virus ,Microbiology ,law.invention ,Antigen ,Species Specificity ,law ,medicine ,Host physiology ,Cellular localization ,biology ,YEAST HOST STRAIN ,HEPATITIS C VIRUS ,General Medicine ,biology.organism_classification ,Molecular biology ,Yeast ,Recombinant Proteins ,Recombinant DNA ,Hepatitis C Antigens ,RECOMBINANT PROTEIN PRODUCTION ,Hepatitis C viru ,Biotechnology - Abstract
In this study, the production of recombinant Hepatitis C virus (HCV) derived proteins from transformed Saccharomyces cerevisiae yeast cells is reported. Three different yeast strains (GRF18U, BY4743-4A and CENPK 113-5D) have been transformed for the intracellular expression of five antigens of different dimensions (from 32.8 to 85.2 kDa), all derived from the non-structural (NS) region of different HCV viruses' genotypes and posed under the control of a glycolytic promoter. The putative trans-membrane domains contained in four antigens seem responsible of their accumulation as protein aggregates. Good productions of the smaller and of the bigger antigens (50 and 30 mg l-1, respectively) have been observed in simple flask batch cultures. Productions are strongly dependent from the genetic background of the yeast host and from the cellular localization of the antigen, while they appear independent from the growth rate of the transformed hosts. For every recombinant antigen tested, the highest production levels were achieved with the CENPK 113-5D-host strain, while the GRF18U strain shows symptoms of a heavily stressed phenotype. © 2005 Elsevier B.V. All rights reserved.
- Published
- 2004
31. A protein from the hyperthermophilic archaebacterium Sulfolobus solfataricus which assist protein folding at high temperature
- Author
-
A. GUAGLIARDI, L. CERCHIA, M. ROSSI, BARTOLUCCI, SIMONETTA, L. ALBERGHINA, L. FRONTALI, P. SENSI, Guagliardi, A., Cerchia, L., Rossi, M., and Bartolucci, Simonetta
- Published
- 1994
32. Use of recombinant Saccharomyces cerevisiae cells for the utilization of agro-industrial wastes
- Author
-
MARTEGANI, ENZO, PORRO, DANILO, BRAMBILLA, LUCA GIUSEPPE, VANONI, MARCO ERCOLE, ALBERGHINA, LILIA, Compagno, C, Tura, A, Ranzi, BM, L. Alberghina, L. Frontali and P. Sensi, Martegani, E, Compagno, C, Porro, D, Tura, A, Brambilla, L, Vanoni, M, Ranzi, B, and Alberghina, L
- Subjects
Biotechnology - Published
- 1994
33. Analysis of the respiratory activity in growing budding yeast by flow cytometric procedures
- Author
-
PORRO, DANILO, Smeraldi, C, Ranzi, BM, Martegani, E, ALBERGHINA, LILIA, L. Alberghina, L. Frontali and P. Sensi Elsevier, Amsterdam, London, New York, Tokyo, Part II, 577-580, 1994., Porro, D, Smeraldi, C, Ranzi, B, Martegani, E, and Alberghina, L
- Subjects
Biotechnology - Published
- 1994
34. Fusion-fission-mitophagy cycling and metabolic reprogramming coordinate nerve growth factor (NGF)-dependent neuronal differentiation.
- Author
-
Goglia I, Węglarz-Tomczak E, Gioia C, Liu Y, Virtuoso A, Bonanomi M, Gaglio D, Salmistraro N, De Luca C, Papa M, Alberghina L, Westerhoff HV, and Colangelo AM
- Subjects
- Animals, PC12 Cells, Rats, Citric Acid Cycle drug effects, Glycolysis, Computer Simulation, Metabolic Reprogramming, Nerve Growth Factor metabolism, Nerve Growth Factor pharmacology, Nerve Growth Factor genetics, Mitochondrial Dynamics drug effects, Cell Differentiation, Neurons metabolism, Neurons cytology, Neurons drug effects, Mitochondria metabolism, Reactive Oxygen Species metabolism, Mitophagy drug effects
- Abstract
Neuronal differentiation is regulated by nerve growth factor (NGF) and other neurotrophins. We explored the impact of NGF on mitochondrial dynamics and metabolism through time-lapse imaging, metabolomics profiling, and computer modeling studies. We show that NGF may direct differentiation by stimulating fission, thereby causing selective mitochondrial network fragmentation and mitophagy, ultimately leading to increased mitochondrial quality and respiration. Then, we reconstructed the dynamic fusion-fission-mitophagy cycling of mitochondria in a computer model, integrating these processes into a single network mechanism. Both the computational model and the simulations are able to reproduce the proposed mechanism in terms of mitochondrial dynamics, levels of reactive oxygen species (ROS), mitophagy, and mitochondrial quality, thus providing a computational tool for the interpretation of the experimental data and for future studies aiming to detail further the action of NGF on mitochondrial processes. We also show that changes in these mitochondrial processes are intertwined with a metabolic function of NGF in differentiation: NGF directs a profound metabolic rearrangement involving glycolysis, TCA cycle, and the pentose phosphate pathway, altering the redox balance. This metabolic rewiring may ensure: (a) supply of both energy and building blocks for the anabolic processes needed for morphological reorganization, as well as (b) redox homeostasis., (© 2024 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.)
- Published
- 2024
- Full Text
- View/download PDF
35. The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation.
- Author
-
Alberghina L
- Subjects
- Humans, Glycolysis physiology, Oxidative Phosphorylation, Cell Proliferation, Mitochondria metabolism, Saccharomyces cerevisiae, Neoplasms genetics, Neoplasms metabolism
- Abstract
The Warburg effect is the long-standing riddle of cancer biology. How does aerobic glycolysis, inefficient in producing ATP, confer a growth advantage to cancer cells? A new evaluation of a large set of literature findings covering the Warburg effect and its yeast counterpart, the Crabtree effect, led to an innovative working hypothesis presented here. It holds that enhanced glycolysis partially inactivates oxidative phosphorylation to induce functional rewiring of a set of TCA cycle enzymes to generate new non-canonical metabolic pathways that sustain faster growth rates. The hypothesis has been structured by constructing two metabolic maps, one for cancer metabolism and the other for the yeast Crabtree effect. New lines of investigation, suggested by these maps, are discussed as instrumental in leading toward a better understanding of cancer biology in order to allow the development of more efficient metabolism-targeted anticancer drugs.
- Published
- 2023
- Full Text
- View/download PDF
36. Echocardiographic Screening for Rheumatic Heart Disease in a Ugandan Orphanage: Feasibility and Outcomes.
- Author
-
Mapelli M, Zagni P, Calbi V, Fusini L, Twalib A, Ferrara R, Mattavelli I, Alberghina L, Salvioni E, Opira C, Kansiime J, Tamborini G, Pepi M, and Agostoni P
- Abstract
Background: Rheumatic heart disease (RHD) is a major cause of cardiovascular disease in developing nations, leading to more than 230,000 deaths annually. Most patients seek medical care only when long-term structural and hemodynamic complications have already occurred. Echocardiographic screenings ensure the early detection of asymptomatic subjects who could benefit from prophylaxis, monitoring and intervention, when appropriate. The aim of this study is to assess the feasibility of a screening program and the prevalence of RHD in a Ugandan orphanage., Methods: We performed an RHD-focused echocardiogram on all the children (5-14 years old) living in a north Ugandan orphanage. Exams were performed with a portable machine (GE Vivid-I). All the time intervals were recorded (minutes)., Results: A total of 163 asymptomatic children were screened over 8 days (medium age 9.1; 46% male; 17% affected by severe motor impairment). The feasibility rate was 99.4%. An average of 20.4 exams were performed per day, with an average of 15.5 images collected per subject. Pathological mitral regurgitation (MR) was found in 5.5% of subjects, while at least two morphological features of RHD were found in 4.3%, leading to 1 "definite RHD" (0.6%) case and 13 "borderline RHD" cases (8.1%). Six congenital heart defects were also noted (3.7%): four atrial septal defects, one coronary artery fistula and one Patent Ductus Arteriosus., Conclusions: We demonstrated the feasibility of an echocardiographic screening for RHD in an orphanage in Uganda. A few factors, such as good clinical and hygienic care, the availability of antibiotics and closeness to a big hospital, may account for the low prevalence of the disease in our population.
- Published
- 2022
- Full Text
- View/download PDF
37. INTEGRATE: Model-based multi-omics data integration to characterize multi-level metabolic regulation.
- Author
-
Di Filippo M, Pescini D, Galuzzi BG, Bonanomi M, Gaglio D, Mangano E, Consolandi C, Alberghina L, Vanoni M, and Damiani C
- Subjects
- Breast Neoplasms metabolism, Breast Neoplasms pathology, Cell Line, Tumor, Female, Humans, Proof of Concept Study, Computer Simulation, Metabolic Networks and Pathways, Metabolomics, Proteomics, Transcriptome
- Abstract
Metabolism is directly and indirectly fine-tuned by a complex web of interacting regulatory mechanisms that fall into two major classes. On the one hand, the expression level of the catalyzing enzyme sets the maximal theoretical flux level (i.e., the net rate of the reaction) for each enzyme-controlled reaction. On the other hand, metabolic regulation controls the metabolic flux through the interactions of metabolites (substrates, cofactors, allosteric modulators) with the responsible enzyme. High-throughput data, such as metabolomics and transcriptomics data, if analyzed separately, do not accurately characterize the hierarchical regulation of metabolism outlined above. They must be integrated to disassemble the interdependence between different regulatory layers controlling metabolism. To this aim, we propose INTEGRATE, a computational pipeline that integrates metabolomics and transcriptomics data, using constraint-based stoichiometric metabolic models as a scaffold. We compute differential reaction expression from transcriptomics data and use constraint-based modeling to predict if the differential expression of metabolic enzymes directly originates differences in metabolic fluxes. In parallel, we use metabolomics to predict how differences in substrate availability translate into differences in metabolic fluxes. We discriminate fluxes regulated at the metabolic and/or gene expression level by intersecting these two output datasets. We demonstrate the pipeline using a set of immortalized normal and cancer breast cell lines. In a clinical setting, knowing the regulatory level at which a given metabolic reaction is controlled will be valuable to inform targeted, truly personalized therapies in cancer patients., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
38. Transcriptomics and Metabolomics Integration Reveals Redox-Dependent Metabolic Rewiring in Breast Cancer Cells.
- Author
-
Bonanomi M, Salmistraro N, Fiscon G, Conte F, Paci P, Bravatà V, Forte GI, Volpari T, Scorza M, Mastroianni F, D'Errico S, Avolio E, Piccialli G, Colangelo AM, Vanoni M, Gaglio D, and Alberghina L
- Abstract
Rewiring glucose metabolism toward aerobic glycolysis provides cancer cells with a rapid generation of pyruvate, ATP, and NADH, while pyruvate oxidation to lactate guarantees refueling of oxidized NAD
+ to sustain glycolysis. CtPB2, an NADH-dependent transcriptional co-regulator, has been proposed to work as an NADH sensor, linking metabolism to epigenetic transcriptional reprogramming. By integrating metabolomics and transcriptomics in a triple-negative human breast cancer cell line, we show that genetic and pharmacological down-regulation of CtBP2 strongly reduces cell proliferation by modulating the redox balance, nucleotide synthesis, ROS generation, and scavenging. Our data highlight the critical role of NADH in controlling the oncogene-dependent crosstalk between metabolism and the epigenetically mediated transcriptional program that sustains energetic and anabolic demands in cancer cells.- Published
- 2021
- Full Text
- View/download PDF
39. A framework for validating AI in precision medicine: considerations from the European ITFoC consortium.
- Author
-
Tsopra R, Fernandez X, Luchinat C, Alberghina L, Lehrach H, Vanoni M, Dreher F, Sezerman OU, Cuggia M, de Tayrac M, Miklasevics E, Itu LM, Geanta M, Ogilvie L, Godey F, Boldisor CN, Campillo-Gimenez B, Cioroboiu C, Ciusdel CF, Coman S, Hijano Cubelos O, Itu A, Lange B, Le Gallo M, Lespagnol A, Mauri G, Soykam HO, Rance B, Turano P, Tenori L, Vignoli A, Wierling C, Benhabiles N, and Burgun A
- Subjects
- Algorithms, Humans, Machine Learning, Precision Medicine, Artificial Intelligence, Neoplasms
- Abstract
Background: Artificial intelligence (AI) has the potential to transform our healthcare systems significantly. New AI technologies based on machine learning approaches should play a key role in clinical decision-making in the future. However, their implementation in health care settings remains limited, mostly due to a lack of robust validation procedures. There is a need to develop reliable assessment frameworks for the clinical validation of AI. We present here an approach for assessing AI for predicting treatment response in triple-negative breast cancer (TNBC), using real-world data and molecular -omics data from clinical data warehouses and biobanks., Methods: The European "ITFoC (Information Technology for the Future Of Cancer)" consortium designed a framework for the clinical validation of AI technologies for predicting treatment response in oncology., Results: This framework is based on seven key steps specifying: (1) the intended use of AI, (2) the target population, (3) the timing of AI evaluation, (4) the datasets used for evaluation, (5) the procedures used for ensuring data safety (including data quality, privacy and security), (6) the metrics used for measuring performance, and (7) the procedures used to ensure that the AI is explainable. This framework forms the basis of a validation platform that we are building for the "ITFoC Challenge". This community-wide competition will make it possible to assess and compare AI algorithms for predicting the response to TNBC treatments with external real-world datasets., Conclusions: The predictive performance and safety of AI technologies must be assessed in a robust, unbiased and transparent manner before their implementation in healthcare settings. We believe that the consideration of the ITFoC consortium will contribute to the safe transfer and implementation of AI in clinical settings, in the context of precision oncology and personalized care., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
40. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
- Author
-
Caruso A, Caccuri F, Bugatti A, Zani A, Vanoni M, Bonfanti P, Cazzaniga ME, Perno CF, Messa C, and Alberghina L
- Subjects
- Animals, COVID-19 virology, Cell Line, Chlorocebus aethiops, Pandemics prevention & control, RNA, Viral genetics, Vero Cells, Antiviral Agents pharmacology, COVID-19 etiology, Methotrexate pharmacology, SARS-CoV-2 drug effects, Virus Replication drug effects
- Abstract
In early 2020 the new respiratory syndrome COVID-19 (caused by the zoonotic SARS-CoV-2 virus) spread like a pandemic, starting from Wuhan, China, causing severe economic depression. Despite some advances in drug treatments of medical complications in the later stages of the disease, the pandemic's death toll is tragic, as no vaccine or specific antiviral treatment is currently available. By using a systems approach, we identify the host-encoded pathway, which provides ribonucleotides to viral RNA synthesis, as a possible target. We show that methotrexate, an FDA-approved inhibitor of purine biosynthesis, potently inhibits viral RNA replication, viral protein synthesis, and virus release. The effective antiviral methotrexate concentrations are similar to those used for established human therapies using the same drug. Methotrexate should be most effective in patients at the earliest appearance of symptoms to effectively prevent viral replication, diffusion of the infection, and possibly fatal complications., (© 2020 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
41. ROS networks: designs, aging, Parkinson's disease and precision therapies.
- Author
-
N Kolodkin A, Sharma RP, Colangelo AM, Ignatenko A, Martorana F, Jennen D, Briedé JJ, Brady N, Barberis M, Mondeel TDGA, Papa M, Kumar V, Peters B, Skupin A, Alberghina L, Balling R, and Westerhoff HV
- Subjects
- Computational Biology, Humans, Molecular Targeted Therapy, Oxidative Stress, Parkinson Disease physiopathology, Aging, Models, Biological, Parkinson Disease metabolism, Parkinson Disease therapy, Precision Medicine, Reactive Oxygen Species metabolism
- Abstract
How the network around ROS protects against oxidative stress and Parkinson's disease (PD), and how processes at the minutes timescale cause disease and aging after decades, remains enigmatic. Challenging whether the ROS network is as complex as it seems, we built a fairly comprehensive version thereof which we disentangled into a hierarchy of only five simpler subnetworks each delivering one type of robustness. The comprehensive dynamic model described in vitro data sets from two independent laboratories. Notwithstanding its five-fold robustness, it exhibited a relatively sudden breakdown, after some 80 years of virtually steady performance: it predicted aging. PD-related conditions such as lack of DJ-1 protein or increased α-synuclein accelerated the collapse, while antioxidants or caffeine retarded it. Introducing a new concept (aging-time-control coefficient), we found that as many as 25 out of 57 molecular processes controlled aging. We identified new targets for "life-extending interventions": mitochondrial synthesis, KEAP1 degradation, and p62 metabolism.
- Published
- 2020
- Full Text
- View/download PDF
42. Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling.
- Author
-
Gaglio D, Bonanomi M, Valtorta S, Bharat R, Ripamonti M, Conte F, Fiscon G, Righi N, Napodano E, Papa F, Raccagni I, Parker SJ, Cifola I, Camboni T, Paci P, Colangelo AM, Vanoni M, Metallo CM, Moresco RM, and Alberghina L
- Abstract
Background: Rewiring of metabolism induced by oncogenic K-Ras in cancer cells involves both glucose and glutamine utilization sustaining enhanced, unrestricted growth. The development of effective anti-cancer treatments targeting metabolism may be facilitated by the identification and rational combinatorial targeting of metabolic pathways., Methods: We performed mass spectrometric metabolomics analysis in vitro and in vivo experiments to evaluate the efficacy of drugs and identify metabolic connectivity., Results: We show that K-Ras -mutant lung and colon cancer cells exhibit a distinct metabolic rewiring, the latter being more dependent on respiration. Combined treatment with the glutaminase inhibitor CB-839 and the PI3K/aldolase inhibitor NVP-BKM120 more consistently reduces cell growth of tumor xenografts. Maximal growth inhibition correlates with the disruption of redox homeostasis, involving loss of reduced glutathione regeneration, redox cofactors, and a decreased connectivity among metabolites primarily involved in nucleic acid metabolism., Conclusions: Our findings open the way to develop metabolic connectivity profiling as a tool for a selective strategy of combined drug repositioning in precision oncology., Competing Interests: Competing interestsDG, L.A., R.M.M., and SV are inventors on the patent application PCT/EP2019/079843 related to the subject matter of this study. The authors declare no other competing interests., (© The Author(s) 2020.)
- Published
- 2020
- Full Text
- View/download PDF
43. Systems metabolomics: from metabolomic snapshots to design principles.
- Author
-
Damiani C, Gaglio D, Sacco E, Alberghina L, and Vanoni M
- Subjects
- Humans, Metabolomics, Artificial Intelligence, Metabolic Diseases
- Abstract
Metabolomics is a rapidly expanding technology that finds increasing application in a variety of fields, form metabolic disorders to cancer, from nutrition and wellness to design and optimization of cell factories. The integration of metabolic snapshots with metabolic fluxes, physiological readouts, metabolic models, and knowledge-informed Artificial Intelligence tools, is required to obtain a system-level understanding of metabolism. The emerging power of multi-omic approaches and the development of integrated experimental and computational tools, able to dissect metabolic features at cellular and subcellular resolution, provide unprecedented opportunities for understanding design principles of metabolic (dis)regulation and for the development of precision therapies in multifactorial diseases, such as cancer and neurodegenerative diseases., (Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
44. Nicotinamide, Nicotinamide Riboside and Nicotinic Acid-Emerging Roles in Replicative and Chronological Aging in Yeast.
- Author
-
Orlandi I, Alberghina L, and Vai M
- Subjects
- Animals, Humans, NAD metabolism, DNA Replication, Niacin metabolism, Niacinamide analogs & derivatives, Niacinamide metabolism, Pyridinium Compounds metabolism, Saccharomyces cerevisiae growth & development, Saccharomyces cerevisiae metabolism
- Abstract
Nicotinamide, nicotinic acid and nicotinamide riboside are vitamin B3 precursors of NAD
+ in the human diet. NAD+ has a fundamental importance for cellular biology, that derives from its essential role as a cofactor of various metabolic redox reactions, as well as an obligate co-substrate for NAD+ -consuming enzymes which are involved in many fundamental cellular processes including aging/longevity. During aging, a systemic decrease in NAD+ levels takes place, exposing the organism to the risk of a progressive inefficiency of those processes in which NAD+ is required and, consequently, contributing to the age-associated physiological/functional decline. In this context, dietary supplementation with NAD+ precursors is considered a promising strategy to prevent NAD+ decrease and attenuate in such a way several metabolic defects common to the aging process. The metabolism of NAD+ precursors and its impact on cell longevity have benefited greatly from studies performed in the yeast Saccharomyces cerevisiae , which is one of the most established model systems used to study the aging processes of both proliferating (replicative aging) and non-proliferating cells (chronological aging). In this review we summarize important aspects of the role played by nicotinamide, nicotinic acid and nicotinamide riboside in NAD+ metabolism and how each of these NAD+ precursors contribute to the different aspects that influence both replicative and chronological aging. Taken as a whole, the findings provided by the studies carried out in S. cerevisiae are informative for the understanding of the complex dynamic flexibility of NAD+ metabolism, which is essential for the maintenance of cellular fitness and for the development of dietary supplements based on NAD+ precursors.- Published
- 2020
- Full Text
- View/download PDF
45. Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells.
- Author
-
Nobile MS, Votta G, Palorini R, Spolaor S, De Vitto H, Cazzaniga P, Ricciardiello F, Mauri G, Alberghina L, Chiaradonna F, and Besozzi D
- Subjects
- Algorithms, Humans, Mutation, Neoplasms, Software
- Abstract
Motivation: The elucidation of dysfunctional cellular processes that can induce the onset of a disease is a challenging issue from both the experimental and computational perspectives. Here we introduce a novel computational method based on the coupling between fuzzy logic modeling and a global optimization algorithm, whose aims are to (1) predict the emergent dynamical behaviors of highly heterogeneous systems in unperturbed and perturbed conditions, regardless of the availability of quantitative parameters, and (2) determine a minimal set of system components whose perturbation can lead to a desired system response, therefore facilitating the design of a more appropriate experimental strategy., Results: We applied this method to investigate what drives K-ras-induced cancer cells, displaying the typical Warburg effect, to death or survival upon progressive glucose depletion. The optimization analysis allowed to identify new combinations of stimuli that maximize pro-apoptotic processes. Namely, our results provide different evidences of an important protective role for protein kinase A in cancer cells under several cellular stress conditions mimicking tumor behavior. The predictive power of this method could facilitate the assessment of the response of other complex heterogeneous systems to drugs or mutations in fields as medicine and pharmacology, therefore paving the way for the development of novel therapeutic treatments., Availability and Implementation: The source code of FUMOSO is available under the GPL 2.0 license on GitHub at the following URL: https://github.com/aresio/FUMOSO., Supplementary Information: Supplementary data are available at Bioinformatics online., (© The Author(s) 2019. Published by Oxford University Press.)
- Published
- 2020
- Full Text
- View/download PDF
46. Neurons, Glia, Extracellular Matrix and Neurovascular Unit: A Systems Biology Approach to the Complexity of Synaptic Plasticity in Health and Disease.
- Author
-
De Luca C, Colangelo AM, Virtuoso A, Alberghina L, and Papa M
- Subjects
- Animals, Central Nervous System physiology, Epilepsy physiopathology, Humans, Neuroglia cytology, Neurons cytology, Extracellular Matrix physiology, Neuroglia physiology, Neuronal Plasticity, Neurons physiology, Synapses physiology, Systems Biology methods
- Abstract
The synaptic cleft has been vastly investigated in the last decades, leading to a novel and fascinating model of the functional and structural modifications linked to synaptic transmission and brain processing. The classic neurocentric model encompassing the neuronal pre- and post-synaptic terminals partly explains the fine-tuned plastic modifications under both pathological and physiological circumstances. Recent experimental evidence has incontrovertibly added oligodendrocytes, astrocytes, and microglia as pivotal elements for synapse formation and remodeling (tripartite synapse) in both the developing and adult brain. Moreover, synaptic plasticity and its pathological counterpart (maladaptive plasticity) have shown a deep connection with other molecular elements of the extracellular matrix (ECM), once considered as a mere extracellular structural scaffold altogether with the cellular glue (i.e., glia). The ECM adds another level of complexity to the modern model of the synapse, particularly, for the long-term plasticity and circuit maintenance. This model, called tetrapartite synapse, can be further implemented by including the neurovascular unit (NVU) and the immune system. Although they were considered so far as tightly separated from the central nervous system (CNS) plasticity, at least in physiological conditions, recent evidence endorsed these elements as structural and paramount actors in synaptic plasticity. This scenario is, as far as speculations and evidence have shown, a consistent model for both adaptive and maladaptive plasticity. However, a comprehensive understanding of brain processes and circuitry complexity is still lacking. Here we propose that a better interpretation of the CNS complexity can be granted by a systems biology approach through the construction of predictive molecular models that enable to enlighten the regulatory logic of the complex molecular networks underlying brain function in health and disease, thus opening the way to more effective treatments., Competing Interests: The authors declare no conflict of interests.
- Published
- 2020
- Full Text
- View/download PDF
47. From computational genomics to systems metabolomics for precision cancer medicine and drug discovery.
- Author
-
Alberghina L and Piccialli G
- Subjects
- Artificial Intelligence, Humans, Neoplasms genetics, Neoplasms metabolism, Systems Biology methods, Drug Discovery methods, Genomics methods, Metabolomics methods, Neoplasms drug therapy
- Published
- 2020
- Full Text
- View/download PDF
48. Single-cell Digital Twins for Cancer Preclinical Investigation.
- Author
-
Filippo MD, Damiani C, Vanoni M, Maspero D, Mauri G, Alberghina L, and Pescini D
- Subjects
- Humans, Metabolomics methods, Single-Cell Analysis methods, Software, Metabolic Networks and Pathways physiology, Metabolome physiology, Neoplasms metabolism
- Abstract
Laboratory models derived from clinical samples represent a solid platform in preclinical research for drug testing and investigation of disease mechanisms. The integration of these laboratory models with their digital counterparts (i.e., predictive mathematical models) allows to set up digital twins essential to fully exploit their potential to face the enormous molecular complexity of human organisms. In particular, due to the close integration of cell metabolism with all other cellular processes, any perturbation in cellular physiology typically reflect on altered cells metabolic profiling. In this regard, changes in metabolism have been shown, also in our laboratory, to drive a causal role in the emergence of cancer disease. Nevertheless, a unique metabolic program does not describe the altered metabolic profile of all tumour cells due to many causes from genetic variability to intratumour heterogeneous dependency on nutrients consumption and metabolism by multiple co-existing subclones. Currently, fluxomics approaches just match with the necessity of characterizing the overall flux distribution of cells within given samples, by disregarding possible heterogeneous behaviors. For the purpose of stratifying cancer heterogeneous subpopulations, quantification of fluxes at the single-cell level is needed. To this aim, we here present a new computational framework called single-cell Flux Balance Analysis (scFBA) that aims to set up digital metabolic twins in the perspective of being better exploited within a framework that makes also use of laboratory patient cell models. In particular, scFBA aims at integrating single-cell RNA-seq data within computational population models in order to depict a snapshot of the corresponding single-cell metabolic phenotypes at a given moment, together with an unsupervised identification of metabolic subpopulations.
- Published
- 2020
- Full Text
- View/download PDF
49. Differential Modulation of NF- κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules.
- Author
-
Martorana F, Foti M, Virtuoso A, Gaglio D, Aprea F, Latronico T, Rossano R, Riccio P, Papa M, Alberghina L, and Colangelo AM
- Subjects
- Humans, Antioxidants metabolism, Astrocytes metabolism, NF-kappa B genetics, Neurodegenerative Diseases genetics, Neuroprotection genetics, Oxidative Stress genetics
- Abstract
Neuroinflammation, a hallmark of chronic neurodegenerative disorders, is characterized by sustained glial activation and the generation of an inflammatory loop, through the release of cytokines and other neurotoxic mediators that cause oxidative stress and limit functional repair of brain parenchyma. Dietary antioxidants may protect against neurodegenerative diseases by counteracting chronic neuroinflammation and reducing oxidative stress. Here, we describe the effects of a number of natural antioxidants (polyphenols, carotenoids, and thiolic molecules) in rescuing astrocytic function and neuronal viability following glial activation by reducing astrocyte proliferation and restoring astrocytic and neuronal survival and basal levels of reactive oxygen species (ROS). All antioxidant molecules are also effective under conditions of oxidative stress and glutamate toxicity, two maladaptive components of neuroinflammatory processes. Moreover, it is remarkable that their antioxidant and anti-inflammatory activity occurs through differential modulation of NF- κ B binding activity in neurons and astrocytes. In fact, we show that inflammatory stimuli promote a significant induction of NF- κ B binding activity in astrocytes and its concomitant reduction in neurons. These changes are prevented in astrocytes and neurons pretreated with the antioxidant molecules, suggesting that NF- κ B plays a key role in the modulation of survival and anti-inflammatory responses. Finally, we newly demonstrate that effective antigliosis and neuroprotective activity is achieved with a defined cocktail of four natural antioxidants at very low concentrations, suggesting a promising strategy to reduce inflammatory and oxidative damage in neurodegenerative diseases with limited side effects., Competing Interests: The authors declare that there is no conflict of interests regarding the publication of this paper.
- Published
- 2019
- Full Text
- View/download PDF
50. Integration of single-cell RNA-seq data into population models to characterize cancer metabolism.
- Author
-
Damiani C, Maspero D, Di Filippo M, Colombo R, Pescini D, Graudenzi A, Westerhoff HV, Alberghina L, Vanoni M, and Mauri G
- Subjects
- Adenocarcinoma of Lung genetics, Algorithms, Breast Neoplasms genetics, Computer Simulation, Female, Gene Expression Profiling methods, Genetics, Population methods, Humans, Male, Metabolic Networks and Pathways, Neoplasms genetics, Neoplasms metabolism, RNA genetics, Software, Transcriptome genetics, Computational Biology methods, Sequence Analysis, RNA methods, Single-Cell Analysis methods
- Abstract
Metabolic reprogramming is a general feature of cancer cells. Regrettably, the comprehensive quantification of metabolites in biological specimens does not promptly translate into knowledge on the utilization of metabolic pathways. By estimating fluxes across metabolic pathways, computational models hold the promise to bridge this gap between data and biological functionality. These models currently portray the average behavior of cell populations however, masking the inherent heterogeneity that is part and parcel of tumorigenesis as much as drug resistance. To remove this limitation, we propose single-cell Flux Balance Analysis (scFBA) as a computational framework to translate single-cell transcriptomes into single-cell fluxomes. We show that the integration of single-cell RNA-seq profiles of cells derived from lung adenocarcinoma and breast cancer patients into a multi-scale stoichiometric model of a cancer cell population: significantly 1) reduces the space of feasible single-cell fluxomes; 2) allows to identify clusters of cells with different growth rates within the population; 3) points out the possible metabolic interactions among cells via exchange of metabolites. The scFBA suite of MATLAB functions is available at https://github.com/BIMIB-DISCo/scFBA, as well as the case study datasets., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.